BRCA1 and ovarian carcinoma: Importantly, annual ovarian surveillance--conducted by pelvic examination, trans-vaginal ultrasound scanning and serum CA125 measurement--in women at increased familial risk of ovarian cancer is found to be ineffective in detecting tumours at a sufficiently early stage, which substantially influences survival in BRCA1/2 mutation carriers[50-52].